Company news

INVO Fertility, Inc. news in 2023

INVO Fertility, Inc.'s news releases, calls and decks from 2023, newest first.

View company

NAYA Biosciences Announces Publication of New Data for its CD38-targeted Flex-NK™ Bispecific Antibody in the American Society of Hematology's Blood Journal

December 10, 2023

INVO Bioscience Regains Compliance with Nasdaq Minimum Stockholders' Equity Requirement

November 27, 2023

INVO Reports Record Third Quarter 2023 Financial Results

November 12, 2023

NAYA Biosciences and INVO Bioscience Announce Appointment of Dr. Peter Kash, Ed.D., MBA as Vice Chairman Following Closing of Their Pending Merger

November 9, 2023

INVO Bioscience Announces Commencement of Waiver Solicitation From Holders of the Company's Common Stock Purchase Warrants

November 8, 2023

INVO Bioscience and NAYA Biosciences Announce Definitive Merger Agreement To Establish Expanded Publicly Traded Life Science Company

October 22, 2023

INVO to Participate in the Lytham Partners Fall 2023 Investor Conference

October 10, 2023

INVO bioscience announces adjournment of special meeting of shareholders

September 28, 2023

INVO Reminds Shareholders to Cast Their Vote for Upcoming Special Meeting of Shareholders to be held on Friday, September 29, 2023 at 12: 00 p.m. ET

September 27, 2023

INVO Reports Second Quarter 2023 Financial Results

August 13, 2023

INVO Closes Acquisition of Wisconsin Fertility Institute

August 10, 2023

INVO to Report Second Quarter 2023 Financial Results on Monday, August 14, 2023

August 8, 2023

INVO Bioscience Announces Closing of $4.5 Million Public Offering

August 7, 2023

INVO Bioscience Announces Pricing of $4.5 Million Public Offering

August 3, 2023

INVO Sets Revised Closing Date of Wisconsin Fertility Institute Acquisition and Announces Key Operational Trends to Drive Shareholder Value

August 2, 2023

INVO Announces a 1: 20 Reverse Stock Split Effective Pre-Market Opening on July 28, 2023

July 26, 2023

INVO Receives 510(k) FDA Clearance for Expanded Use of the INVOcell Device

June 26, 2023

INVO Reports First Quarter 2023 Financial Results

May 14, 2023

INVO Bioscience to Report First Quarter 2023 Financial Results on Monday, May 15, 2023

May 7, 2023

INVO Reports Fourth Quarter and Full Year 2022 Financial Results

April 16, 2023

INVO Bioscience to Report Fourth Quarter and Fiscal Year 2022 Financial Results on Monday, April 17, 2023

April 10, 2023

INVO Congratulates Wisconsin Fertility Institute on Being Named One of America's Best Fertility Clinics by Newsweek

April 4, 2023

INVO Provides Preliminary Update on FY2022 Financial Results

March 29, 2023

INVO Bioscience Announces Closing of $3.0 Million Registered Direct Offering

March 26, 2023

INVO Bioscience Announces Pricing of $3.0 Million Registered Direct Offering Priced At-The-Market

March 23, 2023

INVO Signs Binding Agreements to Acquire Wisconsin Fertility Institute

March 19, 2023

INVO Bioscience Enters Distribution Agreement for Taiwan

January 4, 2023

INVO Bioscience Engages Nationally Recognized Physician for New Tampa-based INVO Center

January 2, 2023

Decks in 2023